References
Wilschut JM, de Voogt WG. Dizzy spells in a patient with hypertrophic obstructive cardiomyopathy and a pacemaker. Neth Heart J 2011;19 doi:10.1007/s12471-010-0051-7.
Klop B, Scheffer M, Mcfadden E, Bracke F, van Gelder B. Treatment of pacemaker-induced superior vena cava superior syndrome by balloon angioplasty and stenting. Neth Heart J. 2011;19 doi:10.1007/s12471-010-0052-6.
van Hemel NM. Remote monitoring of implanted cardiac devices: a plea for a nationwide exploration. Neth Heart J. 2009;17:434–7.
van Welsenes GH, Borleffs CJW, van Rees JB, van der Wall EE, van Erven L, Schalij MJ. Improvements in 25 years of implantable cardiovertor defibrillatory therapy. Neth Heart J. 2011;19 doi:10.1007/s12471-010-0047-3.
Bracke FA, Dekker LR, van der Voort PH, Meijer A. Primary prevention with the ICD in clinical practice: not as straightforward as the guidelines suggest? Neth Heart J. 2009;17:107–10.
Wilde AA, Simmers TA. Primary prevention with ICDs, are we on the right track? Neth Heart J. 2009;17:92–4.
Costantini O, Hohnloser SH, Kirk MM, Lerman BB, Baker JH, Sethuraman B, et al. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. J Am Coll Cardiol. 2009;53:471–9.
Kraaier K, T. McCracken, van der Palen J, Wilde AAM, Scholten MF. Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators? Neth Heart J. 2011;19 doi:10.1007/s12471-010-0053-5.
Postema PG, Van den Berg MP, Van Tintelen JP, Van den Heuvel F, Grundeken M, Hofman N, et al. Founder mutations in the Netherlands: SCN5a 1795insD, the first described arrhythmia overlap syndrome and one of the largest and best characterised families worldwide. Neth Heart J. 2009;17:422–8.
Hofman N, Jongbloed R, Postema PG, Nannenberg E, Alders M, Wilde AAM. Recurrent and founder mutations in the Netherlands: the long-QT syndrome. Neth Heart J. 2011;19 doi:10.1007/s12471-010-0046-4.
Folkeringa RJ, Tieleman RG, Maessen JG, Prins MH, Nieuwlaat R, Crijns HJGM. Statins do not reduce atrial fibrillation after cardiac valvular surgery. A single centre observational study. Neth Heart J. 2011;19 doi:10.1007/s12471-010-0055-3.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van Hemel, N.M. Fresh Arrhythmia News: Suitable for Daily Use?. Neth Heart J 19, 3–5 (2011). https://doi.org/10.1007/s12471-010-0054-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12471-010-0054-4